Cargando…

A new immunodeficient Duchenne muscular dystrophy rat model to evaluate engraftment after human cell transplantation

Duchenne muscular dystrophy (DMD) is an X-linked fatal muscular disease, affecting one in 3,500 live male births worldwide. Currently, there is no cure for this disease, except for steroid-based treatment to attenuate disease progression. Cell transplantation therapy is a promising therapeutic appro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Masae, Goto, Megumi, Yamanouchi, Keitaro, Sakurai, Hidetoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123282/ https://www.ncbi.nlm.nih.gov/pubmed/37101699 http://dx.doi.org/10.3389/fphys.2023.1094359

Ejemplares similares

Cellular senescence-mediated exacerbation of Duchenne muscular dystrophy
por: Sugihara, Hidetoshi, et al.
Publicado: (2020)

Implications of notch signaling in duchenne muscular dystrophy
por: Den Hartog, Lily, et al.
Publicado: (2022)

In utero transplantation of myoblasts and adipose-derived mesenchymal stem cells to murine models of Duchenne muscular dystrophy does not lead to engraftment and frequently results in fetal death
por: Kihara, Yuki, et al.
Publicado: (2022)

Functional muscle ischemia in Duchenne and Becker muscular dystrophy
por: Thomas, Gail D.
Publicado: (2013)

Duchenne muscular dystrophy: disease mechanism and therapeutic strategies
por: Bez Batti Angulski, Addeli, et al.
Publicado: (2023)

Satellite cell contribution to disease pathology in Duchenne muscular dystrophy
por: Kodippili, Kasun, et al.
Publicado: (2023)

Ketogenic diet containing medium-chain triglyceride ameliorates transcriptome disruption in skeletal muscles of rat models of duchenne muscular dystrophy
por: Fujikura, Yuri, et al.
Publicado: (2022)

Loss of p16/Ink4a drives high frequency of rhabdomyosarcoma in a rat model of Duchenne muscular dystrophy
por: TERAMOTO, Naomi, et al.
Publicado: (2021)

PTX3 Predicts Myocardial Damage and Fibrosis in Duchenne Muscular Dystrophy
por: Farini, Andrea, et al.
Publicado: (2020)

Abnormal Calcium Handling in Duchenne Muscular Dystrophy: Mechanisms and Potential Therapies
por: Mareedu, Satvik, et al.
Publicado: (2021)

Extracellular vesicles and Duchenne muscular dystrophy pathology: Modulators of disease progression
por: Yedigaryan, Laura, et al.
Publicado: (2023)

Macroglossia and less advanced dystrophic change in the tongue muscle of the Duchenne muscular dystrophy rat
por: Yamanouchi, Keitaro, et al.
Publicado: (2022)

Transplantation of human iPSC-derived muscle stem cells in the diaphragm of Duchenne muscular dystrophy model mice
por: Miura, Yasutomo, et al.
Publicado: (2022)

Emerging gene editing strategies for Duchenne muscular dystrophy targeting stem cells
por: Bertoni, Carmen
Publicado: (2014)

Acute blood flow restricted exercise to treat Duchenne muscular dystrophy: would it be efficacious?
por: Loenneke, Jeremy P., et al.
Publicado: (2013)

Duchenne muscular dystrophy disease severity impacts skeletal muscle progenitor cells systemic delivery
por: Saleh, Kholoud K., et al.
Publicado: (2023)

Severe Combined Immunodeficiency with De Novo Duchenne Muscular Dystrophy Mutation
por: Shah, Kevin P., et al.
Publicado: (2021)

Metformin Increases Sarcolemma Integrity and Ameliorates Neuromuscular Deficits in a Murine Model of Duchenne Muscular Dystrophy
por: Dong, Xia, et al.
Publicado: (2021)

The new challenge of “exercise + X″ therapy for Duchenne muscular dystrophy—Individualized identification of exercise tolerance and precise implementation of exercise intervention
por: Su, Yuhui, et al.
Publicado: (2022)

Collagen-VI supplementation by cell transplantation improves muscle regeneration in Ullrich congenital muscular dystrophy model mice
por: Takenaka-Ninagawa, Nana, et al.
Publicado: (2021)

Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)

Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021)

A medium-chain triglyceride containing ketogenic diet exacerbates cardiomyopathy in a CRISPR/Cas9 gene-edited rat model with Duchenne muscular dystrophy
por: Fujikura, Yuri, et al.
Publicado: (2022)

Angiogenesis as a novel therapeutic strategy for Duchenne muscular dystrophy through decreased ischemia and increased satellite cells
por: Shimizu-Motohashi, Yuko, et al.
Publicado: (2014)

Muscle Twitch Kinetics Are Dependent on Muscle Group, Disease State, and Age in Duchenne Muscular Dystrophy Mouse Models
por: Peczkowski, Kyra K., et al.
Publicado: (2020)

Human Skeletal Muscle Cells Derived from the Orbicularis Oculi Have Regenerative Capacity for Duchenne Muscular Dystrophy
por: Yamanaka, Yukito, et al.
Publicado: (2019)

Corrigendum: Muscle Twitch Kinetics Are Dependent on Muscle Group, Disease State, and Age in Duchenne Muscular Dystrophy Mouse Models
por: Peczkowski, Kyra K., et al.
Publicado: (2022)

Hypokalemia complicating Duchenne muscular dystrophy.
por: McDonald, B., et al.
Publicado: (1987)

The role of fibrosis in Duchenne muscular dystrophy
por: KLINGLER, WERNER, et al.
Publicado: (2012)

Delay in Diagnosis of Duchenne Muscular Dystrophy
por: Rao, Vamshi K., et al.
Publicado: (2015)

Circulating Biomarkers for Duchenne Muscular Dystrophy
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2015)

Targeting angiogenesis in Duchenne muscular dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2019)

Regenerative biomarkers for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019)

Eteplirsen in the treatment of Duchenne muscular dystrophy
por: Lim, Kenji Rowel Q, et al.
Publicado: (2017)

Nutritional Challenges in Duchenne Muscular Dystrophy
por: Salera, Simona, et al.
Publicado: (2017)

Lifetime Care of Duchenne Muscular Dystrophy
por: MacKintosh, Erin W., et al.
Publicado: (2020)

The Duchenne muscular dystrophy gene and cancer
por: Jones, Leanne, et al.
Publicado: (2020)

CRISPR Therapeutics for Duchenne Muscular Dystrophy
por: Erkut, Esra, et al.
Publicado: (2022)

Exon-Skipping in Duchenne Muscular Dystrophy
por: Takeda, Shin’ichi, et al.
Publicado: (2021)

Gene Therapy for Duchenne Muscular Dystrophy
por: Elangkovan, Nertiyan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j7l2babpdvrqd0vhoopmdu4pgb